Big Money Sentiment Indicator of Organovo Holdings Inc (NYSEMKT:ONVO) Improves in 2018 Q3 to 1.95

Organovo Holdings, Inc. (NASDAQ:ONVO) Corporate Logo

Positions for Organovo Holdings Inc (NYSEMKT:ONVO)

In Q3 2018 Organovo Holdings Inc (NYSEMKT:ONVO) big money sentiment increased to 1.95, filings reveal. So its up 0.74, from 2018Q2’s 1.21. 43 funds opened new and increased equity positions, while 22 trimmed and sold equity positions in Organovo Holdings Inc so the sentiment is more positive. Funds own 22.83 million shares, up from 21.04 million shares in 2018Q2. Funds holding Organovo Holdings Inc in top 10 changed to 0 from 0 for the same number . In total 7 funds closed positions, 15 reduced and 29 increased. Also 14 funds bought new Organovo Holdings Inc stakes.

Largest Organovo Holdings Inc Shareholders

As of Q3 2018 Penbrook Management Llc has 0.3% invested in Organovo Holdings Inc. Organovo Holdings Inc’s shareholder Lehman Financial Resources Inc. owns 213,542 shares as of Q3 2018. American Financial Group Inc reported 251,500 shares. The California-based fund American Money Management Llc have invested about 0.01% of the institutional investor’s stock portfolio in Organovo Holdings Inc. The Arizona-based fund Cue Financial Group Inc. holds 15,500 shares or 0.01% of their equity exposure.

Organovo Holdings, Inc., an early commercial stage company, creates and creates functional and three-dimensional human tissues for use in medical research and therapeutic applications.The firm is worth $129.05 million. The firm develops 3D human tissue models through internal development and in collaboration with pharmaceutical, academic, and other partners.Last it reported negative earnings. The Company’s 3D human tissues could be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs.

ONVO is touching $1.08 during the last trading session, after increased 5.88%.Organovo Holdings, Inc. is downtrending after having declined 27.97% since February 14, 2018. ONVO has 1.04 million volume or 91.34% up from normal. ONVO underperformed by 27.97% the S&P500.

Marco Inv Mngmt Ltd has 0% invested in Organovo Holdings, Inc. (NASDAQ:ONVO) for 10,000 shs. 14,301 were reported by Nikko Asset Mgmt Americas. The New York-based Peconic Prns Ltd has invested 0.01% in Organovo Holdings, Inc. (NASDAQ:ONVO). Moreover, Cortland Associate Mo has 0% invested in Organovo Holdings, Inc. (NASDAQ:ONVO). 12,220 were reported by Creative Planning. Virtu Financial Lc owns 119,836 shs. 13,955 were reported by Proshare Advisors Limited Com. Pennsylvania-based Lehman Fincl Res Inc has invested 0.11% in Organovo Holdings, Inc. (NASDAQ:ONVO). Moreover, Pnc Fincl Serv Grp Inc has 0% invested in Organovo Holdings, Inc. (NASDAQ:ONVO) for 6,600 shs. Goldman Sachs Gp has invested 0% of its capital in Organovo Holdings, Inc. (NASDAQ:ONVO). Ancora Ltd Liability Corp has invested 0% in Organovo Holdings, Inc. (NASDAQ:ONVO). Zurcher Kantonalbank (Zurich Cantonalbank) invested in 0% or 2,108 shs. Moreover, California State Teachers Retirement Systems has 0% invested in Organovo Holdings, Inc. (NASDAQ:ONVO). Credit Agricole S A holds 2,000 shs. Lpl Limited holds 0% or 123,143 shs in its capital.

Organovo Holdings, Inc. had 1 insider sale and 0 insider purchases since November 8, 2018. This’s net activity of $50,800.

For more Organovo Holdings, Inc. (NASDAQ:ONVO) news released recently go to:,,, or The titles are as follows: “Organovo scientific chief bids adieu – Seeking Alpha” released on November 27, 2018, “Organovo Holdings, Inc. (ONVO) CEO Taylor Crouch on Q1 2019 Results – Earnings Call Transcript – Seeking Alpha” on August 09, 2018, “Organovo to Present at 2nd Annual NASH Summit – GlobeNewswire” with a publish date: April 24, 2018, “Organovo – Going The Right Direction – Seeking Alpha” and the last “Organovo Holdings: Print Me A Liver – Seeking Alpha” with publication date: June 14, 2016.

Organovo Holdings, Inc. (NASDAQ:ONVO) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.